Published On : 05 Aug 2016
QYReseachReports.com recently announced the addition of a new research study to its comprehensive collection of research reports. The 130-page research report, titled “Global Non-invasive Prenatal Testing Equipment Market Research Report 2021,” offers a detailed analysis of the market, emphasizing on the key growth drivers, current trends, and opportunities. The historical data and estimated figures related to the non-invasive prenatal testing equipment has been included in the research report.
Non-invasive prenatal testing is a type of genetic test that allows the physician to determine any inherited diseases or birth defects in babies. At present, this testing is made available only to women who have high-risk pregnancies. Some the key tests that are carried out in the non-invasive prenatal testing process are NIFTY, PrenaTest, MaterniT21 PLUS, informaSeq, Harmony, BambniTest, VisibiliT, Panorama, and verify. The growing demand for these tests is estimated to boost the demand for testing equipment in the near future.
The growing number of babies born with Down syndrome and the increasing average maternal age across the globe are some of the key factors anticipated to fuel the growth of the non-invasive prenatal testing equipment market worldwide. In addition, the growing demand for non-invasive and early fetal testing processes is projected to encourage the development of the non-invasive prenatal teasing equipment market in the next few years. On the flip side, technical limitations concerning non-invasive prenatal testing, ethical hurdles, regulatory guidelines, and availability of other testing and screening options are anticipated to curtail the growth of the overall market in the near future.
To get sample copy of report visit @ https://www.qyresearchreports.com/sample/sample.php?rep_id=755030&type=E
By type, the global non-invasive prenatal testing equipment market has been categorized into molecular diagnostics, POC, hematology, tissue diagnostics, immunodiagnostics, and clinical microbiology. The market share and size of each type have been presented in the study to give a clear picture and understanding of the overall market.
The report has classified the global market for non-invasive prenatal testing equipment on the basis of geography into India, Europe, Japan, North America, China, and Southeast Asia. As per the research study, North America is projected to grow at fast pace in the coming few years. Furthermore, Europe is expected to hold the second position in the market. The rapid growth of these regions can be attributed to the large population of women who are preferring late and hence high-risk pregnancies.
The research study analyzes the key companies engaged in the global market for non-invasive prenatal teasing equipment and throws light on the competitive scenario of the market. Some of the prominent players mentioned in the research study are Illumina, Berry Genomics, Safembryo, BGI Genomics, CombiMatrix, Sequenom, LifeCodexx, Genpharm Services, Quest Diagnostics, Laboratory Corporation of America Holdings, LifeLabs Genetics, F. Hoffmann-La Roche, Sengenics, Natera, and Ariosa Diagnostics. Detailed company profiles of these players have been discussed in the scope of the research study.